The addition of insulin, which usually acts as a vasodilatory agent, did not increase MBV or MBF compared with GLP-1 alone, which suggests the presence of microvascular insulin resistance and the insulin-independent effects of GLP-1 on cardiac microvasculature. The gene discussed is INS; the disease is Insulin resistance.